Clinical Trials Directory

Trials / Sponsors / Istari Oncology, Inc.

Istari Oncology, Inc.

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
TerminatedLUMINOS-103: A Basket Trial of Safety & Efficacy of Lerapolturev With or Without Checkpoint Inhibitors
Solid Tumor, Bladder Cancer, Non-muscle-invasive Bladder Cancer
Phase 1 / Phase 22021-08-01
CompletedLUMINOS-102: Lerapolturev With or Without Immune Checkpoint Blockade in Advanced PD-1 Refractory Melanoma
Melanoma
Phase 22020-11-17
CompletedLUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma
Glioblastoma, Recurrent Glioblastoma, Supratentorial Glioblastoma
Phase 22020-10-21
CompletedExamining Bioactivity of PVSRIPO in Invasive Breast Cancer
Invasive Breast Cancer
EARLY_Phase 12019-06-30
TerminatedPVSRIPO for Patients With Unresectable Melanoma
Melanoma
Phase 12018-11-26
CompletedPhase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children
Malignant Glioma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma
Phase 12017-11-07
CompletedLerapolturev in Recurrent Malignant Glioma
Malignant Glioma
Phase 22017-06-01
CompletedPVSRIPO for Recurrent Glioblastoma (GBM)
GBM, Glioblastoma, Glioma
Phase 12012-04-25
No Longer AvailableEAP for the Treatment of Glioblastoma With PVSRIPO
Glioblastoma
——